Fredrick Chalinga: The Science Behind Blood Group Immunogenicity
Fredrick Chalinga, Medical Technologist at Aga Khan University Hospital, shared a post on LinkedIn:
“O-negative is the universal donor.
Yes…but not always.
And surprisingly, Blood Group A is often considered less immunogenic than Blood Group B.
Why? Let’s break it down.
Why is Blood Group A less immunogenic?
The A antigen is structurally closer to naturally occurring substances found in the human body and some bacteria.
Because of this, the immune system tends to react less aggressively against it compared to the B antigen.
This is one reason why:
- Anti-B antibodies are often stronger than Anti-A
- Group B incompatibility reactions can be more severe in some cases
- Blood Group A is generally considered less immunogenic
Why O-negative is NOT always a universal donor?
We usually say O-negative blood is ‘universal’ because it lacks A, B, and Rh(D) antigens.
But red cells carry many other clinically significant antigens besides ABO and Rh.
Examples include:
- Kell
- Duffy
- Kidd
- MNS and others
A patient previously exposed through transfusion or pregnancy may develop antibodies against these antigens.
In such cases, even O-negative blood can trigger a hemolytic transfusion reaction.
This is why:
- Antibody screening matters
- Crossmatching is essential
- ‘Universal donor’ has limitations in real clinical practice
Transfusion medicine is far more complex than just ABO and Rh typing- and that’s what makes Immunohematology fascinating.”
Stay updated with Hemostasis Today.
-
May 28, 2026, 14:21Abdul Mannan: The Hidden Role of Factor XIII in Protecting Clot Stability
-
May 28, 2026, 14:14Spelile Mutupira: Why Hemolysis Remains a Major Laboratory Challenge
-
May 28, 2026, 14:00Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy